Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 13, 2015. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2015. Go to the latest filing (Q3 2026)

6.0B USDQ3 2015
Total value of stock positions
6.0B USD
Positions
40
Share of the ten largest
73.8%

The ten largest positions Q3 2015

  1. Cheniere Energy Inc 18.3%
  2. Viasat Inc 12.4%unchanged
  3. Alcoa Inc 8.5%new
  4. Pioneer Nat Res Co 8.4%▲ +1.8%
  5. Antero Res Corp 5.7%▲ +100.7%
  6. PayPal 5.7%new
  7. Pbf Energy Inc 5.2%unchanged
  8. eBay Inc. 3.8%unchanged
  9. Twenty First Centy Fox Inc 3.0%new
  10. Atara Biotherapeutics Inc 2.8%▲ +11.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q3 2015

Positions Q3 2015 per 13F filing, 40 of 40
Symbol Weight Shares Reported value Change Held since
Cheniere Energy Inc 18.3% 22,669,730 1.1B USD – Q1 2014 7 quarters
Viasat Inc 12.4% 11,533,137 741.5M USD unchanged Q2 2013 or earlier 10 quarters
Alcoa Inc 8.5% 52,270,000 504.9M USD new Q3 2015 1 quarter
Pioneer Nat Res Co 8.4% 4,137,000 503.2M USD +1.8% increased Q1 2015 3 quarters
Antero Res Corp 5.7% 16,099,763 340.7M USD +100.7% increased Q3 2014 5 quarters
PYPL PayPal 5.7% 10,904,852 338.5M USD new Q3 2015 1 quarter
Pbf Energy Inc 5.2% 11,025,000 311.2M USD unchanged Q3 2013 9 quarters
EBAY eBay Inc. 3.8% 9,315,000 227.7M USD unchanged Q2 2014 6 quarters
Twenty First Centy Fox Inc 3.0% 6,527,500 176.7M USD new Q3 2015 1 quarter
Atara Biotherapeutics Inc 2.8% 5,359,632 168.5M USD +11.4% increased Q4 2014 4 quarters
Theravance Inc 2.4% 19,815,983 142.3M USD unchanged Q2 2013 or earlier 10 quarters
Forward Pharma A/S 2.1% 5,367,300 126.5M USD unchanged Q4 2014 4 quarters
Olin Corp 2.0% 7,000,000 117.7M USD new Q3 2015 1 quarter
Twenty First Centy Fox Inc 1.9% 4,097,500 110.6M USD new Q3 2015 1 quarter
Veritiv Corp 1.7% 2,795,693 104.1M USD +12.6% increased Q3 2014 5 quarters
Aercap Holdings NV 1.6% 2,450,000 93.7M USD new Q3 2015 1 quarter
Sunedison Semiconductor Ltd 1.5% 8,372,979 88.3M USD +0.9% increased Q2 2014 6 quarters
Keryx Biopharmaceuticals Inc 1.4% 25,791,678 84.5M USD unchanged Q1 2014 7 quarters
Novagold Res Inc 1.3% 21,688,300 78.3M USD unchanged Q2 2013 or earlier 10 quarters
Theravance Biopharma Inc 1.2% 6,420,028 70.6M USD unchanged Q2 2014 6 quarters
Frontier Communications Corp 1.1% 13,500,000 64.1M USD unchanged Q2 2015 2 quarters
Chipmos Tech Bermuda Ltd 1.0% 3,751,853 61.6M USD +14.3% increased Q2 2013 or earlier 10 quarters
Klx Inc 0.9% 1,500,000 53.6M USD unchanged Q1 2015 3 quarters
Citigroup Inc 0.8% 102,553,207 47.2M USD unchanged Q2 2013 or earlier 10 quarters
Lifelock Inc 0.7% 4,460,760 39.1M USD new Q3 2015 1 quarter
Bellatrix Exploration Ltd 0.6% 23,990,500 36.5M USD +9.8% increased Q4 2014 4 quarters
Ocwen Finl Corp 0.6% 5,200,427 34.9M USD −32.1% reduced Q3 2014 5 quarters
Kosmos Energy Ltd 0.6% 6,000,000 33.5M USD unchanged Q2 2014 6 quarters
Frontier Communications Corp 0.5% 325,000 30.3M USD unchanged Q2 2015 2 quarters
Paratek Pharmaceuticals Inc 0.5% 1,544,498 29.3M USD unchanged Q4 2014 4 quarters
American Intl Group Inc 0.5% 1,258,496 28.6M USD unchanged Q2 2013 or earlier 10 quarters
Biotie Therapies Oyj 0.3% 1,256,006 16.4M USD +44.4% increased Q2 2015 2 quarters
Kindred Biosciences Inc 0.3% 3,013,848 15.7M USD unchanged Q4 2013 8 quarters
MU Micron Technology 0.3% 1,000,000 15.0M USD −94.9% reduced Q2 2013 or earlier 10 quarters
RUN Sunrun 0.2% 1,170,910 12.1M USD new Q3 2015 1 quarter
Alliance One Intl Inc 0.2% 458,364 9.3M USD −28.2% reduced Q2 2015 2 quarters
Alon USA Partners LP 0.1% 363,188 8.5M USD −42.3% reduced Q4 2013 8 quarters
Sanchez Energy Corp 0.1% 1,000,000 6.2M USD +61.4% increased Q2 2015 2 quarters
Novacopper Inc < 0.1% 10,600,758 3.3M USD unchanged Q2 2013 or earlier 10 quarters
Orexigen Therapeutics Inc < 0.1% 821,363 1.5M USD new Q3 2015 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 31.6M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Inc principal 48.2M USD 31.6M USD

Breakdown by sector

  • Financials 5.7%
  • Consumer Discretionary 3.8%
  • Technology 0.3%
  • Industrials 0.2%
  • not in our coverage 90.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close